Could balloon-like water tanks help California prepare for fires? Some call an energy company’s “Water Trees” a game-changing ...

Here’s how it works. The best inflatable hot tubs are essential if you want to create a spa-like experience in the comfort of your own home. Designed to be portable, the best inflatable hot tubs ...

EDE+ fosters a path toward a research career through a unique interdisciplinary approach from its new home in the Chicago Booth School of Business, exposing students to leading researchers in ...

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Deadbeat drivers racked up $5.1 billion in unpaid MTA tolls and violations over four years — a number likely sent skyrocketing since “cashless” systems replaced the old payment booths ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

LAWRENCE, Kan. – With the first game at the reimagined David Booth Kansas Memorial Stadium seven months and one day away, the interior of the upgraded stadium is starting to come to life with detailed ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...